Interactions between FKBP5 variation and environmental stressors in adolescent Major Depression.


Journal

Psychoneuroendocrinology
ISSN: 1873-3360
Titre abrégé: Psychoneuroendocrinology
Pays: England
ID NLM: 7612148

Informations de publication

Date de publication:
08 2019
Historique:
received: 26 09 2018
revised: 25 03 2019
accepted: 25 03 2019
pubmed: 7 4 2019
medline: 1 4 2020
entrez: 7 4 2019
Statut: ppublish

Résumé

Major Depression (MD) results from a complex interplay between environmental stressors and biological factors. Previous studies in adults have shown that adverse life events interact with genetic variation in FKBP5, a gene implicated in the stress-response system, to predict depressive symptoms and MD. This is the first study to investigate interactions between FKBP5 variants and a range of environmental stressors in adolescents with a clinical diagnosis of MD. 148 male and female adolescents with MD and 143 typically developing (TD) controls (13-18 years) were included in the present study. For self-reported environmental stressors, subjective severity was assessed to allow a classification of these factors as mild, moderate and severe. Sociodemographic stressors were assessed via parental-report. With a heightened number of sociodemographic, moderate and total number of stressors, participants carrying at least one copy of the FKBP5 CATT haplotype or at least one minor allele of various FKBP5 SNPs had the highest risk for being in the MD group. No genetic main effects were found. Sociodemographic stressors as well as self-reported mild, moderate, and severe stressors were more common in depressed than in TD adolescents. This is the first study to show interactions between genetic variation in FKBP5 and environmental stressors in a sample of clinically depressed adolescents. The current study provides important starting-points for preventive efforts and highlights the need for a fine-grained analysis of different forms and severities of environmental stressors and their interplay with genetic variation for understanding the complex etiology of (youth) MD.

Identifiants

pubmed: 30953930
pii: S0306-4530(18)31016-3
doi: 10.1016/j.psyneuen.2019.03.025
pii:
doi:

Substances chimiques

Tacrolimus Binding Proteins EC 5.2.1.-
tacrolimus binding protein 5 EC 5.2.1.8

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

28-37

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Auteurs

Charlotte Elisabeth Piechaczek (CE)

Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, University Hospital, LMU Munich, Nußbaumstr. 5A, 80336 Munich, Germany. Electronic address: Charlotte.Piechaczek@med.uni-muenchen.de.

Ellen Greimel (E)

Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, University Hospital, LMU Munich, Nußbaumstr. 5A, 80336 Munich, Germany.

Lisa Feldmann (L)

Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, University Hospital, LMU Munich, Nußbaumstr. 5A, 80336 Munich, Germany.

Verena Pehl (V)

Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, University Hospital, LMU Munich, Nußbaumstr. 5A, 80336 Munich, Germany.

Antje-Kathrin Allgaier (AK)

Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, University Hospital, LMU Munich, Nußbaumstr. 5A, 80336 Munich, Germany; Faculty of Social Sciences, Department of Psychology, University of the German Armed Forces, Werner-Heisenberg-Weg 39, 85577 Neubiberg, Germany.

Michael Frey (M)

Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, University Hospital, LMU Munich, Nußbaumstr. 5A, 80336 Munich, Germany.

Franz Joseph Freisleder (FJ)

KBO Heckscher-Klinikum, Deisenhofenerstr. 28, 81539 Munich, Germany.

Thorhildur Halldorsdottir (T)

Department of Translational Research in Psychiatry, Max-Planck Institute of Psychiatry, Kraepelinstr. 2-10, 80804 Munich, Germany; Centre of Public Health Sciences, Faculty of Medicine, University of Iceland, Vatnsmýrarvegur 16, 101 Reykjavík, Iceland.

Elisabeth B Binder (EB)

Department of Translational Research in Psychiatry, Max-Planck Institute of Psychiatry, Kraepelinstr. 2-10, 80804 Munich, Germany; Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, 12 Executive Park Dr NE #200, Atlanta, GA 30329, USA.

Marcus Ising (M)

Max Planck Institute of Psychiatry, Kraepelinstr. 2-10, 80804 Munich, Germany.

Gerd Schulte-Körne (G)

Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, University Hospital, LMU Munich, Nußbaumstr. 5A, 80336 Munich, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH